Tech Company Financing Transactions
Manifold Bio Funding Round
Manifold Bio, based in Allston, scored $55 million from Roche Venture Fund.
Transaction Overview
Company Name
Announced On
11/3/2025
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Undisclosed
Investors
Roche Venture Fund (Boris Zaïtra)
Proceeds Purpose
The partnership will apply Manifold's proprietary tissue-targeting shuttle portfolio and mDesign AI-driven in vivo discovery engine to create multiple next-generation BBB shuttles for the treatment of neurological and neurodegenerative diseases.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
127 Western Ave.
Allston, MA 02134
USA
Allston, MA 02134
USA
Phone
Undisclosed
Website
Email Address
Overview
Manifold Bio's mission is to build technology that exponentially increases measurement throughput at all stages of drug development. Increasing the number of drugs tested in these representative systems would provide data for learning design principles of drugs with optimal and unique properties in the most challenging disease environments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gleb Kuznetsov
Chief Scientific Officer
Pierce Ogden
Co-Founder
George Church
VP - Bus. Development
Shane Lofgren
Browse more venture capital transactions:
Prev: 11/3/2025: Teleskope venture capital transaction
Next: 11/3/2025: Scavenger AI venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs